Successful Therapy of Murine Visceral Leishmaniasis with Astrakurkurone, a Triterpene Isolated from the Mushroom Astraeus hygrometricus, Involves the Induction of Protective Cell-Mediated Immunity and TLR9

Author:

Mallick Suvadip1,Dutta Aritri1,Chaudhuri Ankur2,Mukherjee Debasri3,Dey Somaditya1,Halder Subhadra13,Ghosh Joydip1,Mukherjee Debarati1,Sultana Sirin Salma1,Biswas Gunjan4,Lai Tapan Kumar4,Patra Pradyumna15,Sarkar Indranil5,Chakraborty Sibani2,Saha Bhaskar3,Acharya Krishnendu4,Pal Chiranjib1

Affiliation:

1. Cellular Immunology and Experimental Therapeutics Laboratory, Department of Zoology, West Bengal State University, Barasat, West Bengal, India

2. Department of Microbiology, West Bengal State University, Barasat, West Bengal, India

3. National Centre for Cell Science, Ganeshkhind, Pune, Maharashtra, India

4. Molecular and Applied Mycology and Plant Pathology Laboratory, Department of Botany, University of Calcutta, West Bengal, India

5. Canning Subdivisional Hospital, Canning, South 24 Parganas, West Bengal, India

Abstract

ABSTRACT In our previous report, we showed that astrakurkurone, a triterpene isolated from the Indian mushroom Astraeus hygrometricus (Pers.) Morgan, induced reactive oxygen species, leading to apoptosis in Leishmania donovani promastigotes, and also was effective in inhibiting intracellular amastigotes at the 50% inhibitory concentration of 2.5 μg/ml. The aim of the present study is to characterize the associated immunomodulatory potentials and cellular activation provided by astrakurkurone, leading to effective antileishmanial activity in vitro and in vivo . Astrakurkurone-mediated antileishmanial activity was evaluated by real-time PCR and flow cytometry. The involvement of Toll-like receptor 9 (TLR9) was studied by in vitro assay in the presence of a TLR9 agonist and antagonist and by in silico modeling of a three-dimensional structure of the ectodomain of TLR9 and its interaction with astrakurkurone. Astrakurkurone caused a significant increase in TLR9 expression of L. donovani -infected macrophages along with the activation of proinflammatory responses. The involvement of TLR9 in astrakurkurone-mediated amastigote killing has been evidenced from the fact that a TLR9 agonist (CpG, ODN 1826) in combination with astrakurkurone enhanced the amastigote killing, while a TLR9 antagonist (bafilomycin A1) alone or in combination with astrakurkurone curbed the amastigote killing, which could be further justified by in silico evidence of docking between mouse TLR9 and astrakurkurone. Astrakurkurone was found to reduce the parasite burden in vivo by inducing protective cytokines, gamma interferon and interleukin 17. Moreover, astrakurkurone was nontoxic toward peripheral blood mononuclear cells of immunocompromised patients with visceral leishmaniasis. Astrakurkurone, a nontoxic antileishmanial, enhances the immune efficiency of host cells, leading to parasite clearance in vitro and in vivo .

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Reference43 articles.

1. World Health Organization. 2015. Leishmaniasis fact sheet 375. World Health Organizatio, Geneva, Switzerland. http://www.who.int/mediacentre/factsheets/fs375/en/.

2. Efficacy and Safety of Amphotericin B Emulsion versus Liposomal Formulation in Indian Patients with Visceral Leishmaniasis: A Randomized, Open-Label Study

3. Relapse of visceral leishmaniasis after miltefosine treatment in a Nepalese patient;Pandey BD;Am J Trop Med Hyg,2009

4. World Health Organization. 22 to 26 March 2010. Control of the leishmaniasis: report of a meeting of the WHO Expert Committee on the Control of Leishmaniases. World Health Organization, Geneva, Switzerland. http://whqlibdoc.who.int/trs/WHO_TRS_949_eng.pdf.

5. World Health Organization and Southeast Asia Regional Office. 2015. Regional strategic framework for elimination of Kala-azar from the Southeast Asia Region (2005-2015): WHO project IND CRD 714. World Health Organization, Geneva, Switzerland. http://209.61.208.233/LinkFiles/Kala_azar_VBC-85_Rev_1.pdf.

Cited by 24 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3